SoundHound AI, Inc. (NASDAQ:SOUNW) Short Interest Up 268.1% in November
by Amy Steele · The Cerbat GemSoundHound AI, Inc. (NASDAQ:SOUNW – Get Free Report) was the target of a large growth in short interest during the month of November. As of November 15th, there was short interest totalling 17,300 shares, a growth of 268.1% from the October 31st total of 4,700 shares. Based on an average daily volume of 47,500 shares, the short-interest ratio is currently 0.4 days.
SoundHound AI Trading Up 2.4 %
NASDAQ:SOUNW traded up $0.07 during mid-day trading on Wednesday, hitting $2.96. The stock had a trading volume of 35,377 shares, compared to its average volume of 142,551. SoundHound AI has a twelve month low of $0.23 and a twelve month high of $5.98. The company’s 50 day simple moving average is $2.07 and its 200 day simple moving average is $2.00.
SoundHound AI Company Profile
SoundHound AI, Inc develops independent voice artificial intelligence (AI) solutions that enables businesses across automotive, TV, and IoT, and to customer service industries to deliver high-quality conversational experiences to their customers. Its products include Houndify platform that offers a suite of Houndify tools to help brands build conversational voice assistants, such as Application Programming Interfaces (API) for text and voice queries, support for custom commands, extensive library of content domains, inclusive software development kit platforms, collaboration capabilities, diagnostic tools, and built-in analytics; SoundHound Chat AI that integrates with knowledge domains, pulling real-time data like weather, sports, stocks, flight status, and restaurants; and SoundHound Smart Answering is built to offer customer establishments custom AI-powered voice assistant.
Read More
- Five stocks we like better than SoundHound AI
- Investing in Construction Stocks
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Stock Average Calculator
- 2 Generic Drug Stocks Ready to Surge in 2025